SERMs (Pharmos)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameSERMs (Pharmos)
Drug Alias Nametamoxifen methiodidetamoxifen methiodide (Pharmos)tamoxifen derivatives (Pharmos)tamoxifen-QTMI
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEstrogen receptor alpha degraders
TargetsEstrogen receptor alpha
Therapy Area/IndicationsCognition DisordersCardiovascular DiseasesOsteoporosis +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPharmos Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPharmos Corp
Active IndicationsN/A
Inactive IndicationsCognition DisordersCardiovascular DiseasesOsteoporosis +[4] 

Other Information

ATC CodeN/A
Related LinksN/A